We are live on ! Find out more
FLGT icon

Fulgent Genetics

86 hedge funds and large institutions have $106M invested in Fulgent Genetics in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 21

15% more funds holding

Funds holding: 7586 (+11)

9% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 22

24% less capital invested

Capital invested by funds: $138M → $106M (-$32.8M)

29.54% less ownership

Funds ownership: 59.69%30.16% (-30%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
86
Holders Change
+11
Holders Change %
+14.67%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
34
Increased
20
Reduced
22
Closed
21
Calls
Puts
Net Calls
Net Calls Change

FLGT Hedge Fund Activity: Q2 2020 in Review

86 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2020, worth a combined $106M — down 24% from $138M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new FLGT positions and 21 closed out — a net gain of 13 holders — while 20 added to existing stakes and 22 trimmed.

The largest buyer was BlackRock, adding an estimated $8.55M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $7.19M sold.

  • 86 institutional investors held Fulgent Genetics (FLGT) as of Q2 2020, up from 75 in Q1 2020.
  • Funds reported $106M of Fulgent Genetics stock for Q2 2020, down 24% quarter-over-quarter.
  • 34 funds opened new Fulgent Genetics positions in Q2 2020 and 21 closed out, a net change of +13 holders.
  • The largest Fulgent Genetics buyer in Q2 2020 was BlackRock, an estimated $8.55M added.
  • The largest Fulgent Genetics seller in Q2 2020 was Driehaus Capital Management, an estimated $7.19M sold.

Based on aggregated 13F filings for Q2 2020.